Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Revenues $ 3,657,798 $ 2,937,325 $ 7,173,614 $ 5,020,275
Revenues from related party 22,014,878 22,014,878
Total revenues 25,672,676 2,937,325 29,188,492 5,020,275
Cost of revenues 16,745,553 913,357 18,000,343 1,802,226
Gross profit 8,927,123 2,023,968 11,188,149 3,218,049
Operating expenses:        
Personnel 825,130 284,886 1,498,504 469,557
Marketing and promotion 76,060 77,943 194,959 129,704
General and administrative 2,676,454 1,220,103 4,357,476 2,486,798
Total operating expenses 3,577,644 1,582,932 6,050,939 3,086,059
Operating income (loss) 5,349,479 441,036 5,137,210 131,990
Non-operating income (expenses):        
Interest expense (2,619,460) (286,258) (4,560,007) (602,519)
Interest income 64,345 19,072 346,754 38,906
Loss on debt settlements (563,119) (1,776,960)
Equity in earnings of investments (45,465) 1,912,942
Other 2,948,917 (3,600) 2,948,917 (3,600)
Total non-operating income (expenses) 348,337 (833,905) 648,606 (2,344,173)
Income (loss) before income taxes 5,697,816 (392,869) 5,785,816 (2,212,183)
Provision for income taxes 974,584 (189) 984,595 12,407
Net income (loss) 4,723,232 (392,680) 4,801,221 (2,224,590)
Net income (loss) attributable to noncontrolling interests 46,147 69,287 147,346 132,520
Net income (loss) attributable to MariMed Inc. $ 4,677,085 $ (461,967) $ 4,653,875 $ (2,357,110)
Net income (loss) per share        
Basic $ 0.022 $ (0.002) $ 0.022 $ (0.013)
Diluted $ 0.02 $ (0.002) $ 0.02 $ (0.013)
Weighted average common shares outstanding        
Basic 213,319,149 186,645,833 211,510,986 182,746,858
Diluted 232,828,964 186,645,833 231,020,801 182,746,858